Charles Rhyee
Stock Analyst at TD Cowen
(1.99)
# 3,080
Out of 5,124 analysts
64
Total ratings
43.18%
Success rate
-7.75%
Average return
Main Sectors:
Stocks Rated by Charles Rhyee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GDRX GoodRx Holdings | Maintains: Buy | $7 → $6 | $2.90 | +106.90% | 8 | Nov 10, 2025 | |
| CRL Charles River Laboratories International | Maintains: Buy | $205 → $197 | $216.11 | -8.84% | 6 | Nov 10, 2025 | |
| COR Cencora | Maintains: Buy | $350 → $400 | $346.17 | +15.55% | 1 | Nov 10, 2025 | |
| CI The Cigna Group | Maintains: Buy | $387 → $333 | $284.76 | +16.94% | 1 | Nov 4, 2025 | |
| CVS CVS Health | Maintains: Buy | $99 → $100 | $80.70 | +23.92% | 1 | Nov 3, 2025 | |
| CAH Cardinal Health | Maintains: Buy | $183 → $225 | $208.48 | +7.92% | 3 | Nov 3, 2025 | |
| OPCH Option Care Health | Maintains: Hold | $30 → $27 | $32.79 | -17.66% | 2 | Nov 3, 2025 | |
| IQV IQVIA Holdings | Downgrades: Hold | $206 → $215 | $240.53 | -10.61% | 2 | Nov 3, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Hold | $183 → $172 | $201.48 | -14.63% | 5 | Oct 24, 2025 | |
| MEDP Medpace Holdings | Maintains: Sell | $356 → $462 | $608.89 | -24.12% | 6 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $297 → $380 | $237.87 | +59.75% | 4 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $830 → $864 | $826.51 | +4.54% | 4 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $23 → $25 | $17.54 | +42.53% | 3 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $9 → $8 | $8.00 | - | 6 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $4 → $5 | $3.92 | +27.55% | 2 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $100 → $50 | $5.33 | +838.09% | 3 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $56 | $15.59 | +259.20% | 2 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $360 → $280 | $13.48 | +1,977.15% | 3 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $48 → $50 | $4.02 | +1,143.78% | 2 | Jun 21, 2022 |
GoodRx Holdings
Nov 10, 2025
Maintains: Buy
Price Target: $7 → $6
Current: $2.90
Upside: +106.90%
Charles River Laboratories International
Nov 10, 2025
Maintains: Buy
Price Target: $205 → $197
Current: $216.11
Upside: -8.84%
Cencora
Nov 10, 2025
Maintains: Buy
Price Target: $350 → $400
Current: $346.17
Upside: +15.55%
The Cigna Group
Nov 4, 2025
Maintains: Buy
Price Target: $387 → $333
Current: $284.76
Upside: +16.94%
CVS Health
Nov 3, 2025
Maintains: Buy
Price Target: $99 → $100
Current: $80.70
Upside: +23.92%
Cardinal Health
Nov 3, 2025
Maintains: Buy
Price Target: $183 → $225
Current: $208.48
Upside: +7.92%
Option Care Health
Nov 3, 2025
Maintains: Hold
Price Target: $30 → $27
Current: $32.79
Upside: -17.66%
IQVIA Holdings
Nov 3, 2025
Downgrades: Hold
Price Target: $206 → $215
Current: $240.53
Upside: -10.61%
ICON Public Limited Company
Oct 24, 2025
Maintains: Hold
Price Target: $183 → $172
Current: $201.48
Upside: -14.63%
Medpace Holdings
Oct 24, 2025
Maintains: Sell
Price Target: $356 → $462
Current: $608.89
Upside: -24.12%
Oct 7, 2025
Upgrades: Buy
Price Target: $297 → $380
Current: $237.87
Upside: +59.75%
Sep 24, 2025
Maintains: Buy
Price Target: $830 → $864
Current: $826.51
Upside: +4.54%
Nov 11, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $17.54
Upside: +42.53%
Oct 31, 2024
Maintains: Hold
Price Target: $9 → $8
Current: $8.00
Upside: -
May 3, 2023
Maintains: Outperform
Price Target: $4 → $5
Current: $3.92
Upside: +27.55%
Mar 23, 2023
Downgrades: Market Perform
Price Target: $100 → $50
Current: $5.33
Upside: +838.09%
Oct 20, 2022
Maintains: Outperform
Price Target: $70 → $56
Current: $15.59
Upside: +259.20%
Aug 16, 2022
Maintains: Outperform
Price Target: $360 → $280
Current: $13.48
Upside: +1,977.15%
Jun 21, 2022
Maintains: Outperform
Price Target: $48 → $50
Current: $4.02
Upside: +1,143.78%